knowledge -WSS

knowledge

author：comprehensive 2025-09-04 04:25:29 - browse：17

Adobe

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient its business around selling its products directly to users over the counter, rather than by prescription.

In connection with the move away from prescription sales, Akili will reduce its workforce by 40%, which the company projects will extend its runway into the second half of 2025. The Boston-based company will continue offering its pediatric treatment, EndeavorRx, by prescription until it can convert it to over-the-counter labeling — it plans to submit data to FDA in 2024.

Akili went public last year and though its prescription sales were slowly increasing, the company’s costs far outstripped its revenues. In its second-quarter results reported in August, Akili said it earned just $114,000 on $15.3 million in expenses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

WSS

Mike Pence clashes with Tucker Carlson in Iowa

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Investment in vaccine development is lagging, report finds

Zyn nicotine pouches become unlikely player in latest culture war

Celiac disease study examines precisely how gluten triggers injury

hotspot

knowledge

leisure time

Jerome Adams on the need for new antivirals for Covid

Mike Pence clashes with Tucker Carlson in Iowa

Wildfire smoke exposes gaps in outdoor worker protections

Investment in vaccine development is lagging, report finds

Affirmative action in medical school literally saved lives

Why police arrested suspected Gilgo Beach killer away from his house

Heart attack and stroke risk calculators need revising

Europe sees delivery challenges ahead on Alzheimer's therapies

Hepatitis C has a cure — but many Americans still lack access to it

Boston competes with Raleigh

focus

Congress likely to miss an opportunity to fix drug shortages issue

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

J&J expands global access to TB drug amid advocacy campaign

White House pharmacy plagued with problems, investigation finds

The Affordable Care Act has saved billions in health care costs

J&J expands global access to TB drug amid advocacy campaign

hotspot

focus

hotspot

leisure time